Baudax Bio (BXRXV) Stock Price, News & Analysis

Company Overview

Baudax Bio, Inc. is a specialty biopharmaceutical company focused on developing and commercializing injectable therapies for acute care hospital settings. The company’s strategy centers on addressing unmet medical needs in perioperative and postoperative care by advancing novel formulations of established active pharmaceutical ingredients. Baudax Bio’s approach seeks to combine well‐characterized molecules with improved delivery methods to enhance safety, efficacy and patient comfort.

The company’s lead product candidate is an intravenous formulation of tramadol, a centrally acting analgesic with a well‐understood safety profile. This proprietary IV tramadol therapy is being evaluated in late‐stage clinical trials for the management of moderate to severe acute pain. Baudax Bio has secured rights to this formulation through licensing agreements and is conducting pivotal studies designed to meet U.S. Food and Drug Administration requirements for potential approval and hospital adoption.

Headquartered in Malvern, Pennsylvania, Baudax Bio serves a predominantly U.S. acute care market while exploring potential partnerships for international distribution. The company’s management team brings experience in pharmaceutical development, regulatory affairs and commercial launch in hospital settings. By focusing on injectable acute care products, Baudax Bio aims to create a differentiated portfolio that addresses clinician and patient needs in high‐intensity clinical environments.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 119,000 shs
• Average Volume: 53,220 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BXRXV Stock Analysis - Frequently Asked Questions

How do I buy shares of Baudax Bio?

Shares of BXRXV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BXRXV
• CIK: N/A
• Web: www.baudaxbio.com
• Phone: N/A
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A